Laura dos Santos Boeira

Laura dos Santos Boeira

Auto-generated profile, based on publicly available information

Laura dos Santos Boeira

Graduate Program in Psychology, Pontifical Catholic University of Rio Grande do Sul, Porto Alegre, Brazil

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 March 2022 in Health Research Policy and Systems
Verified
Journal Article
Open access
PDF file
TKTanja Kuchenmüller
Tanja Kuchenmüller
LBLaura Boeira
Laura Boeira
SOSandy Oliver
Sandy Oliver
KMKaelan Moat
Kaelan Moat
FEFadi El-Jardali
Fadi El-Jardali
JLJohn Lavis
John Lavis
Background: While calls for institutionalization of evidence-informed policy-making (EIP) have become stronger in recent years, there is a paucity of methods that governments and organizational knowledge brokers can use to sustain and integrate EIP as part of mainstream health policy-making. The objective of this paper was to conduct a knowledge synthesis of the published and grey literatures to develop a theoretical framework with the key features of EIP institutionalization.Methods: We applied a critical interpretive synthesis (CIS) that allowed for a systematic, yet iterative and dynamic analysis of heterogeneous bodies of literature to develop an explanatory framework for EIP institutionalization. We used a “compass” question to create a detailed search strategy and conducted electronic searches to identify papers based on their potential relevance to EIP institutionalization. Papers were screened and extracted independently and in duplicate. A constant comparative method was applied to develop a framework on EIP institutionalization. The CIS was triangulated with the findings of stakeholder dialogues that involved civil servants, policy-makers and researchers.Results: We identified 3001 references, of which 88 papers met our eligibility criteria. This CIS resulted in a definition of EIP institutionalization as the “process and outcome of (re-)creating, maintaining and reinforcing norms, regulations, and standard practices that, based on collective meaning and values, actions as well as endowment of resources, allow evidence to become—over time—a legitimate and taken-for-granted part of health policy-making”. The resulting theoretical framework comprised six key domains of EIP institutionalization that capture both structure and agency: (1) governance; (2) standards and routinized processes; (3) partnership, collective action and support; (4) leadership and commitment; (5) resources; and (6) culture. Furthermore, EIP institutionalization is being achieved through five overlapping stages: (i) precipitating events; (ii) de-institutionalization; (iii) semi-institutionalization (comprising theorization and diffusion); (iv) (re)-institutionalization; and (v) renewed de-institutionalization processes.Conclusions: This CIS advances the theoretical and conceptual discussions on EIP institutionalization, and provides new insights into an evidence-informed framework for initiating, strengthening and/or assessing efforts to institutionalize EIP.

17 September 2019 in Palgrave Communications
Verified
Journal Article
Open access
PDF file
KAKaren Akerlof
Karen Akerlof
CTChris Tyler
Chris Tyler
SFSarah Elizabeth Foxen
Sarah Elizabeth Foxen
EHErin Heath
Erin Heath
MSMarga Gual Soler
Marga Gual Soler
Masaru YarimeMasaru Yarime
Masaru Yarime
The quantity and complexity of scientific and technological information provided to policymakers have been on the rise for decades. Yet little is known about how to provide science advice to legislatures, even though scientific information is widely acknowledged as valuable for decision-making in many policy domains. We asked academics, science advisers, and policymakers from both developed and developing nations to identify, review and refine, and then rank the most pressing research questions on legislative science advice (LSA). Experts generally agree that the state of evidence is poor, especially regarding developing and lower-middle income countries. Many fundamental questions about science advice processes remain unanswered and are of great interest: whether legislative use of scientific evidence improves the implementation and outcome of social programs and policies; under what conditions legislators and staff seek out scientific information or use what is presented to them; and how different communication channels affect informational trust and use. Environment and health are the highest priority policy domains for the field. The context-specific nature of many of the submitted questions—whether to policy issues, institutions, or locations—suggests one of the significant challenges is aggregating generalizable evidence on LSA practices. Understanding these research needs represents a first step in advancing a global agenda for LSA research.

10 November 2021 in Public Health Research and Practice
Verified
Journal Article
Open access
Francisco Becerra-PosadaFrancisco Becerra-Posada
Francisco Becerra-Posada
LBLaura dos Santos Boeira
Laura dos Santos Boeira
BGBárbara García-Godoy
Bárbara García-Godoy
ELElizabeth Lloyd
Elizabeth Lloyd
HMHéctor Martínez-Sánchez
Héctor Martínez-Sánchez
MBMauricio Bustamante-Garcia
Mauricio Bustamante-Garcia
Objectives and importance of study: The importance of health policy and systems research (HPSR) has been acknowledged since 2004 and was recognised by the United Nations World Health Assembly in 2005. However, many factors influence its development. This paper aims to analyse the impact of politics and political determinants on HPSR funding in selected countries of Latin America and the Caribbean. Methods: Using a standardised protocol, we performed an analysis of available data and financing structures for health research and HPSR, based on research in eight countries, including interviews with key stakeholders (n = 42). Results: Dollar depreciation and gross national product growth in the region may play a role in how governments fund research. There have been shifts in the political spectrum in governments, which have affected research coordination and funding in positive and negative ways. HPSR funding in some countries was dependent on budget decisions and although some have improved funding, others have regressed by decreasing funding or have completely cancelled financing mechanisms. Caribbean countries rely mainly on institutional funding. HPSR is recognised as important but remains underfunded; stakeholders believed it should be used more in decision making. Conclusion: Although HPSR is recognised as valuable for decision making and policy development, it does not have the financial support required to flourish in Latin America and the Carribean. Data on health research financing were not easy to access. There was little or no evidence of published reports or papers about research financing, health research funding, and HPSR funding in particular in the studied countries. Because of the fragility of health systems highlighted by the coronavirus disease 2019 (COVID-19) pandemic, HPSR should be of great relevance and value to both policy makers and funders.

16 February 2022 in PLOS ONE
Verified
Journal Article
Open access
PDF file
CMCristian Mansilla
Cristian Mansilla
CHCristian A. Herrera
Cristian A. Herrera
LBLaura Boeira
Laura Boeira
AYAndrea Yearwood
Andrea Yearwood
ALAnalia S. Lopez
Analia S. Lopez
LRLudovic Reveiz
Ludovic Reveiz
Introduction: The Coronavirus Disease 2019 (COVID19) pandemic has struck Latin America and the Caribbean (LAC) particularly hard. One of the crucial areas in the international community’s response relates to accelerating research and knowledge sharing. The aim of this article is to map and characterise the existing empirical research related to COVID-19 in LAC countries and contribute to identify opportunities for strengthening future research. Methods: In this scoping review, articles published between December 2019 and 11 November 2020 were selected if they included an empirical component (explicit scientific methods to collect and analyse primary data), LAC population was researched, and the research was about the COVID-19 pandemic, regardless of publication status or language. MEDLINE, EMBASE, LILACS, Scielo, CENTRAL and Epistemonikos were searched. All titles and abstracts, and full texts were screened by two independent reviewers. Data from included studies was extracted by one reviewer and checked by a second independent reviewer. Results: 14,406 records were found. After removing duplicates, 5,458 titles and abstracts were screened, of which 2,323 full texts were revised to finally include 1,626 empirical studies. The largest portion of research came from people/population of Brazil (54.6%), Mexico (19.1%), Colombia (11.2%), Argentina (10.4%), Peru (10.3%) and Chile (10%), while Caribbean countries concentrated 15.3%. The methodologies most used were cross-sectional studies (34.7%), simulation models (17.5%) and randomized controlled trials (RCTs) (13.6%). Using a modified version of WHO’s COVID-19 Coordinated Global Research Roadmap classification, 54.2% were epidemiological studies, followed by clinical management (22.3%) and candidate therapeutics (12.2%). Government and public funds support were reported in 19.2% of studies, followed by universities or research centres (9%), but 47.5% did not include any funding statement. Conclusion: During the first part of the COVID-19 pandemic, LAC countries have contributed to the global research effort primarily with epidemiological studies, with little participation on vaccines research, meaning that this type of knowledge would be imported from elsewhere. Research agendas could be further coordinated aiming to enhance shared self-sufficiency regarding knowledge needs in the region.

23 January 2025 in BMJ Evidence-Based Medicine
Verified
Journal Article
Open access
PDF file
LBLaura Boeira
Laura Boeira
EHEmily Hayter
Emily Hayter
SOSandy Oliver
Sandy Oliver
LMLaurenz Mahlanza-Langer
Laurenz Mahlanza-Langer
DSDonald Simeon
Donald Simeon
TKTanja Kuchenmuller
Tanja Kuchenmuller
The importance of EIDM in shaping global health policies and practices has gained considerable recognition, particularly as many countries experimented with and created new ways of applying evidence to policy-making during the COVID-19 pandemic.5 EIDM also plays a critical role in achieving the Sustainable Development Goals. In response to this growing importance, the Evidence-informed Policy Network (EVIPNet), a key initiative of WHO to increase country capacity in accessing and using the best available evidence, issued a call for action in 2021,6 highlighting the need to strengthen the institutionalisation of EIDM structures and processes that are demand-driven, ethical and multidisciplinary.

12 October 2023 in Health Research Policy and Systems
Verified
Journal Article
Open access
PDF file
JBJorge Otávio Maia Barreto
Jorge Otávio Maia Barreto
DRDavi Mamblona Marques Romão
Davi Mamblona Marques Romão
CSCecilia Setti
Cecilia Setti
MMMaria Lúcia Teixeira Machado
Maria Lúcia Teixeira Machado
RRRachel Riera
Rachel Riera
SSSilvio Fernandes da Silva
Silvio Fernandes da Silva
Background: Evidence-informed policymaking (EIPM) requires a set of individual and organizational knowledge, skills and attitudes that should be articulated with background factors and needs. In this regard, the development of an EIPM competency profile is important to support the diagnosis, planning and implementation of EIPM. Purpose: To present the process and outcomes of the development of an EIPM competency profile by an expert committee, to be applied in different contexts of the Brazilian Health System. Methods: A committee of experts in EIPM shared different views, experiences and opinions to develop an EIPM competency profile for Brazil. In six consensus workshops mediated by facilitators, the committee defined from macro problems to key actions and performances essential for the competency profile. The development steps consisted of: (1) Constitution of the committee, including researchers, professionals with practical experience, managers, and educators; (2) Development of a rapid review on EIPM competency profiles; (3) Agreement on commitments and responsibilities in the processes; (4) Identification and definition of macro problems relating to the scope of the competency profile; and (5) Outlining of general and specific capacities, to be incorporated into the competency profile, categorized by key actions. Results: The development of the EIPM competency profile was guided by the following macro problems: (1) lack of systematic and transparent decision-making processes in health policy management; (2) underdeveloped institutional capacity for knowledge management and translation; and (3) incipient use of scientific evidence in the formulation and implementation of health policies. A general framework of key actions and performances of the EIPM Competency Profile for Brazil was developed, including 42 specific and general key actions distributed by area of activity (Health Management, Scientific Research, Civil Society, Knowledge Translation, and Cross-sectional areas). Conclusions: The competency profile presented in this article can be used in different contexts as a key tool for the institutionalization of EIPM.